Cargando…
SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world
[Figure: see text]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290867/ https://www.ncbi.nlm.nih.gov/pubmed/37287082 http://dx.doi.org/10.1093/eurheartj/ehad282 |
| _version_ | 1785062581839331328 |
|---|---|
| author | Marx, Nikolaus Müller-Wieland, Dirk |
| author_facet | Marx, Nikolaus Müller-Wieland, Dirk |
| author_sort | Marx, Nikolaus |
| collection | PubMed |
| description | [Figure: see text] |
| format | Online Article Text |
| id | pubmed-10290867 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102908672023-06-26 SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world Marx, Nikolaus Müller-Wieland, Dirk Eur Heart J Clinical Research [Figure: see text] Oxford University Press 2023-06-08 /pmc/articles/PMC10290867/ /pubmed/37287082 http://dx.doi.org/10.1093/eurheartj/ehad282 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Clinical Research Marx, Nikolaus Müller-Wieland, Dirk SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world |
| title | SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world |
| title_full | SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world |
| title_fullStr | SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world |
| title_full_unstemmed | SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world |
| title_short | SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world |
| title_sort | sglt2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world |
| topic | Clinical Research |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290867/ https://www.ncbi.nlm.nih.gov/pubmed/37287082 http://dx.doi.org/10.1093/eurheartj/ehad282 |
| work_keys_str_mv | AT marxnikolaus sglt2inhibitorsinheartfailureandtype2diabetesfromefficacyintrialstowardseffectivenessintherealworld AT mullerwielanddirk sglt2inhibitorsinheartfailureandtype2diabetesfromefficacyintrialstowardseffectivenessintherealworld |